9.705
price down icon3.43%   -0.345
pre-market  Pre-market:  9.40   -0.305   -3.14%
loading

Cns Pharmaceuticals Inc Stock (CNSP) Forecast

The Cns Pharmaceuticals Inc (CNSP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $9.37, representing a -3.45% decrease from the current price of $9.705. The highest analyst price target is $9.0107, and the lowest is $9.7292.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNSP Price Target
Average 16.30 (+67.91% Upside)
loading

Is Cns Pharmaceuticals Inc (CNSP) A Buy Now?

Oscillators
Name Value Action
RSI(14) 60.86 Neutral
STOCH(9,6) 85.40 Sell
STOCHRSI(14) 28.79 Neutral
MACD(12,26) 0.6492 Buy
ADX(14) 31.85 Buy
William %R -30.79 Neutral
CCI(14) 68.12 Neutral
Buy: 2 Sell: 1 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
9.4229
Buy
9.4997
Buy
MA20
9.0289
Buy
8.9543
Buy
MA50
7.5565
Buy
8.6409
Buy
MA100
9.1359
Buy
15.96
Sell
MA200
23.55
Sell
86.30
Sell
Buy: 7 Sell: 3 Neutral: 0
Summary: Buy
According to our latest analysis, CNSP could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 4 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on CNSP, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 60.86 indicates that CNSP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 85.4 indicates that CNSP is oversold. This means that CNSP price is at or near the highest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.79 indicates that CNSP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 31.85 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 68.12 indicates that CNSP is still overbought but not to an extreme extent.

Long-term CNSP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Cns Pharmaceuticals Inc financial reports and earnings history, Cns Pharmaceuticals Inc (CNSP) stock could reach $38.97 by 2030, $70.10 by 2040 and $319.69 by 2050. See the projected annual prices until 2050 of the Cns Pharmaceuticals Inc stock below:

  • Cns Pharmaceuticals Inc (CNSP) is expected to reach an average price of $74.03 in 2035, with a high prediction of $75.20 and a low estimate of $74.62. This indicates an $662.79% rise from the last recorded price of $9.705.
  • Cns Pharmaceuticals Inc (CNSP) stock is projected to chart a bullish course in 2040, with an average price target of $68.15, representing an $602.21% surge from its current level. The forecast ranges from a conservative $68.22 to a sky-high $70.10.
  • Our analysts predict Cns Pharmaceuticals Inc (CNSP) to jump 259.39% by 2045, soaring from $36.04 to an average price of $34.88, potentially reaching $39.12. While $36.04 is the low estimate, the potential upside is significant.
  • Cns Pharmaceuticals Inc (CNSP) stock is expected to climb by 2050, reaching an average of $319.80, a $3,195% jump from its current level. However, a wide range of estimates exists, with high and low targets of $319.69 and $322.20, respectively, highlighting the market's uncertainty.

Cns Pharmaceuticals Inc Stock (CNSP) Year by Year Forecast

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2025

Cns Pharmaceuticals Inc Stock (CNSP) is expected to reach an average price of $25.20 in 2025, with a high prediction of $49.96 and a low estimate of $0.438. This indicates an +159.64% rise from the last recorded price of $9.705.
Month Average Low High Change from today's price
November, 2025 $14.60 $9.7292 $9.0107 +50.47%
December, 2025 $16.39 $14.38 $15.43 +68.86%

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2026

The predicted value for Cns Pharmaceuticals Inc (CNSP) in 2026 is set at an average of $19.55. Estimates vary from a peak of $22.86 to a trough of $16.25, indicating an +101.48% surge from the present price of $9.705.
Month Average Low High Change from today's price
January, 2026 $23.21 $21.54 $22.86 +139.14%
February, 2026 $22.51 $23.23 $22.22 +131.90%
March, 2026 $20.60 $21.75 $21.15 +112.29%
April, 2026 $21.45 $20.62 $20.43 +121.00%
May, 2026 $19.42 $20.50 $20.76 +100.07%
June, 2026 $19.73 $20.38 $19.97 +103.30%
July, 2026 $20.28 $19.98 $19.81 +108.99%
August, 2026 $18.15 $19.23 $19.27 +86.97%
September, 2026 $18.86 $17.81 $17.52 +94.29%
October, 2026 $18.04 $18.04 $17.93 +85.87%
November, 2026 $16.93 $17.20 $17.76 +74.43%
December, 2026 $18.55 $16.25 $18.47 +91.15%

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Cns Pharmaceuticals Inc (CNSP) is $12.20, with a high forecast of $18.02 and a low forecast of $6.3775. This indicates an +25.69% increase from the last price of $9.705.
Month Average Low High Change from today's price
January, 2027 $17.43 $17.98 $18.02 +79.65%
February, 2027 $17.12 $17.17 $17.28 +76.39%
March, 2027 $16.22 $16.51 $16.54 +67.15%
April, 2027 $15.93 $16.08 $15.93 +64.10%
May, 2027 $14.17 $14.38 $15.63 +46.01%
June, 2027 $12.96 $13.18 $13.71 +33.56%
July, 2027 $11.64 $11.88 $12.67 +19.90%
August, 2027 $10.65 $10.67 $11.14 +9.75%
September, 2027 $9.5034 $9.5634 $10.29 -2.08%
October, 2027 $8.8375 $8.8475 $9.2519 -8.94%
November, 2027 $8.3816 $8.5016 $8.556 -13.64%
December, 2027 $6.1943 $6.3775 $8.0202 -36.17%

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2028

In 2028, Cns Pharmaceuticals Inc (CNSP) is projected to reach an average price of $27.77, with a high projection of $55.28 and a low estimate of $0.2653. This indicates an +186.18% rise from the last price of $9.705.
Month Average Low High Change from today's price
January, 2028 $4.8784 $5.2984 $5.8848 -49.73%
February, 2028 $4.5225 $4.584 $4.627 -53.40%
March, 2028 $4.2152 $4.3466 $4.3495 -56.57%
April, 2028 $3.7112 $3.752 $4.0747 -61.76%
May, 2028 $2.302 $2.4119 $3.4206 -76.28%
June, 2028 $1.4674 $1.476 $2.0024 -84.88%
July, 2028 $0.5087 $0.5201 $1.195 -94.76%
August, 2028 $39.48 $0.2653 $55.28 +306.79%
September, 2028 $52.17 $45.58 $46.47 +437.53%
October, 2028 $49.56 $52.86 $50.56 +410.62%
November, 2028 $40.44 $43.74 $49.05 +316.70%
December, 2028 $34.23 $37.03 $36.04 +252.70%

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2029

The 2029 price forecast for Cns Pharmaceuticals Inc Stock (CNSP) is $23.76 on average, with a high prediction of $44.01 and a low estimate of $3.5003. This represents an +144.80% increase from the previous price of $9.705.
Month Average Low High Change from today's price
January, 2029 $45.21 $32.30 $44.01 +365.89%
February, 2029 $3.2974 $42.71 $39.61 -66.02%
March, 2029 $24.99 $3.5003 $36.80 +157.50%
April, 2029 $21.78 $16.43 $20.28 +124.41%
May, 2029 $30.96 $22.48 $27.06 +219.06%
June, 2029 $33.45 $34.95 $32.96 +244.69%
July, 2029 $24.84 $27.54 $25.94 +155.96%
August, 2029 $31.03 $29.14 $28.93 +219.69%
September, 2029 $37.41 $33.92 $32.50 +285.52%
October, 2029 $33.40 $32.31 $30.41 +244.15%
November, 2029 $32.89 $35.79 $33.39 +238.87%
December, 2029 $38.08 $33.58 $33.88 +292.33%

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2030

Cns Pharmaceuticals Inc Stock (CNSP) is expected to reach an average price of $47.65 in 2030, with a high forecast of $56.53 and a low forecast of $38.77. This signifies an +390.98% surge from the last price of $9.705.
Month Average Low High Change from today's price
January, 2030 $43.51 $38.77 $38.97 +348.34%
February, 2030 $50.28 $45.96 $44.69 +418.06%
March, 2030 $51.84 $49.80 $49.24 +434.11%
April, 2030 $57.21 $51.57 $56.53 +489.49%
May, 2030 $54.91 $55.84 $56.03 +465.80%
June, 2030 $52.00 $53.39 $53.04 +435.83%
July, 2030 $51.59 $51.49 $50.57 +431.59%
August, 2030 $48.55 $49.63 $50.65 +400.29%
September, 2030 $47.86 $48.52 $48.60 +393.16%
October, 2030 $47.16 $47.61 $47.33 +385.89%
November, 2030 $44.01 $45.10 $45.89 +353.50%
December, 2030 $42.58 $42.67 $43.13 +338.77%
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Cap:     |  Volume (24h):